Valuing Intangible Assets Precisely
Specialized valuation for pharma, biotech, cosmetics, and food manufacturing
About Us
Specializing in valuation of intangible assets for pharma and healthcare manufacturing AWA Beyond Finance
The AWA Methodology enables a facility to recognize and retain an extraordinary uplift in value that current models entirely overlook. Our analysis demonstrates that the measured non-tangible assets can conservatively generate an extra value percentage that may reach four to five times the current valuation of the facility's tangible assets alone.
By implementing the AWA Methodology, businesses can achieve a truer, significantly higher valuation of their core manufacturing infrastructure, unlocking previously inaccessible capital and strategic advantages.
AWA Methodology, described as the world's first structured approach to quantifying intangible manufacturing assets with scientific precision. It is designed for highly regulated sectors like:
Pharmaceuticals
Biotechnology
Cosmetics
Food Industries
The industry challenges in valuation AWA Beyond Finance
The Problem: Undervaluation
Traditional Valuation: Focuses only on tangible elements (machinery, utilities, infrastructure) and IP (patents, trademarks).
The Gap: It ignores "operational excellence"—the systems, knowledge, and processes that allow a facility to operate at industrial standards.
Consequence: Facilities are often undervalued by a factor of 2x, 3x, or even 4x their real worth because their regulatory maturity and internal processes are not reflected in financial numbers.
The Solution: AWA Methodology Parameters
The system uses a matrix of 310 parameters to evaluate non-tangible assets, independent of the products produced. These parameters cover:
Manufacturing & Process Validation: 40 parameters
Quality Management System (QMS): 40 parameters
Quality Assurance: 44 parameters
Quality Control: 50 parameters
Environmental Sustainability: 50 parameters
Digialization & Automation: 30 parameters
Archiving & Documentation: 25 parameters
Operational Sustainability: 25 parameters
Facilities & Equipment: 25 parameters
Research & Development: 25 parameters
Vendor & Supplier Management: 15 parameters
Our Services
Specialized valuation of intangible assets in healthcare manufacturing.
Intangible Asset Valuation & goodwill
Expert assessment of non-physical assets in pharma and biotech.
Regulatory Process Insights
Valuing expertise gained through regulatory and product development.
diagnostics for area requires developments
Assessment from management to policy & procedures
Stay Informed
Subscribe for insights on intangible asset valuation
Contact Us
Reach out for expert intangible asset valuation.